News tagged with pulmonary tb
The link between TB and a gene mutation that causes lung cancer
Tuberculosis (TB) has been suspected to increase a person's risk of lung cancer because the pulmonary inflammation and fibrosis can induce genetic damage. However, direct evidence of specific genetic changes and the disease ...
Jan 18, 2012 |
not rated yet |
0
New tuberculosis research movement needed
In this week's PLoS Medicine, Christian Lienhardt from the WHO in Geneva, Switzerland and colleagues announce that the Stop TB Partnership and the WHO Stop TB Department have launched the TB Research Movement.
Nov 30, 2011 |
2 / 5 (1) |
0
Serological antibody tests to detect active tuberculosis are inaccurate and not cost-effective
Despite being widely available for sale in low-and-middle income countries, commercial serological tests used to detect active tuberculosis (by identifying antibodies to the tuberculosis-causing bacterium in a blood sample) ...
Aug 09, 2011 |
not rated yet |
0
Highlight: New TB diagnostic proves effective, expedient, study finds
A molecular test designed to easily diagnose tuberculosis (TB) and detect a drug-resistant form of the bacterium that causes TB can provide much more specific, sensitive and rapid results than currently available TB diagnostics, ...
Sep 01, 2010 |
5 / 5 (1) |
0
Study establishes most effective technique for diagnosing childhood tuberculosis in poor countries
A tuberculosis (TB) culture method called microscopic-observation drug-susceptibility (MODS), using two gastric aspirate specimens from each child tested, is significantly more sensitive and faster than conventional culture ...
Jul 25, 2010 |
not rated yet |
0
New test quickly ID's active TB in smear-negative patients
Active tuberculosis can be rapidly identified in patients with negative sputum tests by a new method, according to European researchers. Active tuberculosis (TB) is the seventh-leading cause of death worldwide, and while ...
Sep 23, 2009 |
not rated yet |
0
TB vaccine enters new clinical trials
(PhysOrg.com) -- The world’s leading candidate for a tuberculosis vaccine, developed at the University of Oxford, is to enter Phase IIb proof-of-concept clinical trials, making it the first TB candidate vaccine ...
Medicine & Health / Medications
Apr 23, 2009 |
1 / 5 (1) |
0
Slow-growing TB bacteria point the way to new drug development
The discovery of a large number of slow-growing Mycobacterium tuberculosis bacteria, which cause tuberculosis (TB), in the lungs of TB patients could be an important step forward in the design of new anti-TB drugs.
Mar 30, 2009 |
1 / 5 (1) |
1
